FDA Adverse Event Injury Summary report: N

GMK-SPHERE TIBIAL TRAY FIXED CEMENTED SIZE 3 L

MDR report key: 18510520 · Received January 15, 2024

Report

Report Number
3005180920-2023-01106
Event Type
Injury
Date Received
January 15, 2024
Date of Event
December 21, 2023
Report Date
January 15, 2024
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JWH
UDI-DI
07630030819889
PMA / PMN Number
K090988
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON 28-DEC-2023, LOT 2210918: 24 ITEMS MANUFACTURED AND RELEASED ON 21-SEP-2022. EXPIRATION DATE: 2027-09-07. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, 23 ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF REVIEW. ADDITIONAL IMPLANTS INVOLVED IN THE EVENT, BATCH REVIEW PERFORMED ON 28-DEC-2023. GMK-SPHERE 02.12.0023L FEMORAL COMPONENT SPHERE CEMENTED SIZE 3+ L (K140826) LOT. 2215962. LOT 2215962: 36 ITEMS MANUFACTURED AND RELEASED ON 19-OCT-2022. EXPIRATION DATE: 2027-10-09. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, 32 ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF REVIEW. GMK-SPHERE 02.12.0314FL TIBIAL INSERT FIXED SPHERE FLEX #3/14 MM L (K121416) LOT. 187216, LOT 187216: 30 ITEMS MANUFACTURED AND RELEASED ON 03-JAN-19. EXPIRATION DATE: 2023-12-11. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, 19 ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF REVIEW.

Description of Event or Problem · 0

AT ABOUT 10 MONTHS AFTER PRIMARY, THE PATIENT CAME IN REPORTING INSTABILITY AND THE CAUSE IS UNKNOWN. THE SURGEON REVISED ALL COMPONENTS TO REVISION COMPONENTS AND THE SURGERY COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
644650 GMK-SPHERE TIBIAL TRAY FIXED CEMENTED SIZE 3 L TIBIAL TRAY FIXED CEMENTED JWH MEDACTA INTERNATIONAL SA 2210918 07630030819889

Patients

Seq Age Sex Outcome Treatment
1 Female Required Intervention